Toshio Kashihara
Takeda Pharmaceutical Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshio Kashihara.
Pharmaceutical Research | 1995
Yohko Akiyama; Naoki Nagahara; Toshio Kashihara; Shin-Ichiro Hirai; Hajime Toguchi
Two types of polyglycerol ester of fatty acid (PGEF)-based microspheres were prepared: Carbopol 934P (CP)-coated microspheres (CPC-microspheres) and CP-dispersion microspheres (CPD-microspheres). Comparative studies on mucoadhesion were done with these microspheres and PGEF-based microspheres without CP (PGEF-microspheres). In an in vitro adhesion test, the CPD-microspheres adhered strongly to mucosa prepared from rat stomach and small intestine because each CP particle in the CPD-microsphere was hydrated and swelled with part of it remaining within the microsphere and part extending to the surface serving to anchor the microsphere to the mucus layer. The gastrointestinal transit patterns after administration of the CPD-microspheres and PGEF-microspheres to fasted rats were fitted to a model in which the microspheres are emptied from the stomach monoexponentially with a lag time and then transit through the small intestine at zero-order. Parameters obtained by curve fitting confirmed that the gastrointestinal transit time of the CPD-microspheres was prolonged compared with that of the PGEF-microspheres. MRT in the gastrointestinal tract was also prolonged after administration of the CPD-microspheres compared with that following the administration of the PGEF-microspheres.
Drug Development and Industrial Pharmacy | 1992
Tetsuro Tabata; Tadashi Makino; Toshio Kashihara; Shin-Ichiro Hirai; Nobuyuki Kitamori; Hajime Toguchi
AbstractIn the previous study, we clarified that enteric granules were appropriate dosage forms of lansoprazole. The establishment of these formulations, however, was difficult because some of the excipients needed for these formulations are incompatible with the drug. We examined the effects of adding magnesium carbonate as an alkaline stabilizer and could get stable enteric granules. We also discuss the mechanism of stabilization.
Archive | 1990
Shunichi Itoh; Hiroyoshi Koyama; Toshio Kashihara; Shin-Ichiro Hirai
Archive | 1991
Minoru Yoshioka; Hidetoshi Horibe; Toshio Kashihara
International Journal of Pharmaceutics | 2004
Shinji Ohmori; Yasuo Ohno; Tadashi Makino; Toshio Kashihara
European Journal of Pharmaceutics and Biopharmaceutics | 2005
Shinji Ohmori; Yasuo Ohno; Tadashi Makino; Toshio Kashihara
International Journal of Pharmaceutics | 2004
Shinji Ohmori; Yasuo Ohno; Tadashi Makino; Toshio Kashihara
Archive | 1994
Hiroshi Matoba; Shinji Ohmori; Hiroyoshi Koyama; Toshio Kashihara
Chemical & Pharmaceutical Bulletin | 2004
Shinji Ohmori; Yasuo Ohno; Tadashi Makino; Toshio Kashihara
Archive | 1994
Toshio Kashihara; Hiroyoshi Koyama; Hiroshi Matoba; Shinji Ohmori